Contact us : info@bioworlde.com
Home > Product > COVID-19&Infectious disease series
Bunyamwera orthobunyavirus Nucleocapsid Protein(BUNV-NP) NCP0161
  • Bunyamwera orthobunyavirus Nucleocapsid Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Product NameBunyamwera orthobunyavirus Nucleocapsid Protein(BUNV-NP)
Catalog No.NCP0161
Swiss-ProtNP_047213.1
Host His-tag
ReactivityE. coli Expression
ApplicationsReseach
Application_allReseach
BiowMW699bp
Purification&PurityTransferred into competent cells and the supernatant was purified by NI column affinity chromatography and the purity is > 85% (by SDS-PAGE).
Browse similar products>>
Size Price
100ug $398
1mg $2980
Add to cart My orders
Product Name :
Bunyamwera orthobunyavirus Nucleocapsid Protein(BUNV-NP)
Background :
The bunyavirus nucleocapsid protein, N, is a multifunctional protein that encapsidates each of the three negative-sense genome segments to form ribonucleoprotein complexes that are the functional templates for viral transcription and replication. In addition, N protein molecules interact with themselves to form oligomers, with the viral L (RNA polymerase) protein, with the carboxy-terminal regions of either or both of the virion glycoproteins, and probably also with host cell proteins. Bunyamwera virus (BUNV), the prototype bunyavirus, encodes an N protein of 233 amino acids in length.
Product :
Inclusion body;0.5mol Urea,PH=8
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
Carrier:pET30a-BUNV-NP-His(C-term) Virus:N protein [Bunyamwera virus]
Immunogen :
pathway :
  • Bunyamwera orthobunyavirus Nucleocapsid Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Blocking peptide available as NCP0161P
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER